Singapore markets open in 5 hours 41 minutes

Precision BioSciences, Inc. (DTIL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2250+0.0050 (+0.41%)
As of 03:18PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 140.74M
Enterprise value -15.53M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.11
Price/book (mrq)1.37
Enterprise value/revenue -0.41
Enterprise value/EBITDA 0.19

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3-90.30%
S&P500 52-week change 3-16.88%
52-week high 312.8700
52-week low 31.1100
50-day moving average 31.6162
200-day moving average 33.1838

Share statistics

Avg vol (3-month) 32.28M
Avg vol (10-day) 31.15M
Shares outstanding 5110.82M
Implied shares outstanding 6N/A
Float 880.36M
% held by insiders 117.01%
% held by institutions 153.42%
Shares short (30 Aug 2022) 41.07M
Short ratio (30 Aug 2022) 40.69
Short % of float (30 Aug 2022) 41.00%
Short % of shares outstanding (30 Aug 2022) 40.97%
Shares short (prior month 28 Jul 2022) 41.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -247.31%
Operating margin (ttm)-264.55%

Management effectiveness

Return on assets (ttm)-23.53%
Return on equity (ttm)-91.14%

Income statement

Revenue (ttm)37.51M
Revenue per share (ttm)0.60
Quarterly revenue growth (yoy)-94.40%
Gross profit (ttm)115.53M
Net income avi to common (ttm)-92.77M
Diluted EPS (ttm)-0.6700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)184.14M
Total cash per share (mrq)1.66
Total debt (mrq)27.87M
Total debt/equity (mrq)27.05
Current ratio (mrq)4.59
Book value per share (mrq)0.93

Cash flow statement

Operating cash flow (ttm)-100.68M
Levered free cash flow (ttm)-67.71M